Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-α) and IFN-γ: IFN-α but not IFN-γ reduces woodchuck hepatitis virus replication in chronic infection in vivo

Journal of Virology

Volumn 78, Issue 18, 2004, Pages 10111-10121

  Fiedler, Melanie ^a   Rödicker, Florian ^a   Salucci, Valentina ^b   Lu, Mengji ^a   Aurisicchio, Luigi ^b   Dahmen, Uta ^a   Jun, Li ^a   Dirsch, Olaf ^a   Pützer, Brigitte M ^a,c   Palombo, Fabio ^b   Roggendorf, Michael ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b IRBM   (Italy)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA INTERFERON; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CENTRAL VEIN; CHRONIC HEPATITIS; DISEASE MODEL; GENE TRANSFER; GENETIC TRANSDUCTION; HEPATITIS VIRUS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION; WOODCHUCK;

ADENOVIRIDAE; ANIMALS; CELLS, CULTURED; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELPER VIRUSES; HEPATITIS B VIRUS, WOODCHUCK; HEPATITIS, VIRAL, ANIMAL; HEPATOCYTES; INTERFERON TYPE II; INTERFERON-ALPHA; LUMINESCENT PROTEINS; MARMOTA; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC; VIRUS REPLICATION;

EID: 4444289122     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.18.10111-10121.2004     Document Type: Article

References (38)

1. Aurisicchio, L., P. Delmastro, V. Salucci, O. G. Paz, P. Rovere, G. Ciliberto, N. La Monica, and F. Palombo. 2000. Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitis. J. Virol. 74:4816-4823.
2. Beasley, R. P., L. Y. Hwang, C. C. Lin, and C. S. Chien. 1981. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2:1129-1133.
3. Cavanaugh, V. J., L. G. Guidotti, and F. V. Chisari. 1998. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus nfcc infections in transgenic mice. J. Virol. 72:2630-2637.
4. Chen, L., M. Anton, and F. L. Graham. 1996. Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre. Somat. Cell Mol. Genet. 22:477-488.
5. Dahmen, U., O. Dirsch, J. Li, M. Fiedler, M. Lu, K. Rispeter, M. Picucci, C. E. Broelsch, and M. Roggendorf. 2004. Adoptive transfer of immunity: a new strategy to interfere with severe hepatitis virus reinfection after woodchuck liver transplantation. Transplantation 77:965-972.
6. Gordien, E., O. Rosmorduc, C. Peltekian, F. Garreau, C. Brechot, and D. Kremsdorf. 2001. Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein. J. Virol. 75:2684-2691.
7. Guidotti, L. G., K. Ando, M. V. Hobbs, T. Ishikawa, R. D. Runkel, R. D. Schreiber, and F. V. Chisari. 1994. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA 91:3764-3768.
8. Guidotti, L. G., P. Borrow, M. V. Hobbs, B. Matzke, I. Gresser, M. B. A. Oldstone, and F. V. Chisari. 1996. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc. Natl. Acad. Sci. USA 93:4589-4594.
9. Guidotti, L. G., and F. V. Chisari. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19:65-91.
10. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25-36.
11. Guidotti, L. G., R. Rochford, L. Chung, M. Shapiro, R. Purcell, and F. V. Chisari. 1999. Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825-829.
12. Guo, J. T., H. Zhou, C. Liu, C. Aldrich, J. Saputelli, T. Whitaker, M. I. Barrasa, W. S. Mason, and C. Seeger. 2000. Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections. J. Virol. 74:1495-1505.
13. Hoofnagle, J. H., and A. M. D. Bisceglie. 1997. The treatment of chronic viral hepatitis. N. Engl. J. Med. 336:347-356.
14. Kakimi, K., L. C. Guidotti, Y. Koezuka, and F. V. Chisari. 2000. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192:921-930.
15. Kasahara, A., N. Hayashi, K. Mochizuki, M. Takayanagi, K. Yoshioka, S. Kakumu, A. lljima, A. Urushihara, K. Kiyosawa, M. Okuda, and K. Hino. 1998. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Hepatology 27:1394-1402.
16. Kim, I. H., A. Jozkowicz, P. A. Piedra, K. Oka, and L. Chan. 2001. Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc. Natl. Acad. Sci. USA 98:13282-13287.
17. Kochanek, S. 1999. High-capacity adenoviral vectors for gene transfer and somatic gene therapy. Hum. Gene Ther. 10:2451-2459.
18. Leifeld, L., J. Ramakers, A. M. Schneiders, F. L. Dumoulin, M. Sterneck, A. Muller, T. Sauerbruch, and U. Spengler. 2001. Intrahepatic MxA expression is correlated with interferon-alpha expression in chronic and fulminant hepatitis. J. Pathol. 194:478-483.
19. Leung, N. 2002. Treatment of chronic hepatitis B: Case selection and duration of therapy. J. Gastroenterol. Hepatol. 17:409-414.
20. Lohrengel, B., M. Lu, and M. Roggendorf. 1998. Molecular cloning of the woodchuck cytokines: TNF-α, IFN-γ, and IL-6. Immunogenetics 47:332-335.
21. Lu, M., G. Hilken, D. Yang, T. Kemper, and M. Roggendorf. 2001. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks. J. Virol. 75:3811-3818.
22. Lu, M., B. Lohrengel, G. Hilken, T. Kemper, and M. Roggendorf. 2002. Woodchuck gamma interferon upregulates major histocompatibility complex class I transcription but is unable to deplete woodchuck hepatitis virus replication intermediates and RNAs in persistently infected woodchuck primary hepatocytes. J. Virol. 76:58-67.
23. Luster, A. D., and J. V. Ravetch. 1987. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J. Exp. Med. 166:1084-1097.
24. McClary, H., R. Koch, F. V. Chisari, and L. G. Guidotti. 2000. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J. Virol. 74:2255-2264.
25. Merle, P., M. Chevallier, R. Levy, M. Maisonnas, O. Terradillos, S. N. S. Ahmed, C. Trepo, M. A. Buendla, and L. Vitvitski-Trepo. 2001. Preliminary results of interferon-alpha therapy on woodchuck hepatitis virus-induced hepatocarcinogenesis: possible benefit in female transgenic mice. J. Hepatol. 34:562-569.
26. Michalak, T. I., P. D. Hodgson, and N. D. Churchill. 2000. Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection. J. Virol. 74:4483-4494.
27. National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
28. Pützer, B. M., T. Stiewe, F. Rödicker, O. Schildgen, S. Rühm, O. Diersch, M. Fiedler, U. Dahmen, B. Tennant, C. Scherer, F. L. Graham, and M. Roggendorf. 2001. Large nontransplanted hepatocellular carcinoma in woodchucks: treatment with adenovirus-mediated delivery of interleukin 12/B7.1 genes. JNCI 93:472-479.
29. Rang, A., M. Bruns, T. Heise, and H. Will. 2002. Antiviral activity of interferon-alpha against hepatitis B virus can be studied in non-hepatic cells and is independent of MxA. J. Biol. Chem. 277:7645-7647.
30. Rodicker, F., T. Stiewe, S. Zimmermann, and B. M. Putzer. 2001. Therapeutic efficacy of E2F1 in pancreatic cancer correlates with TP73 induction. Cancer Res. 61:7052-7055.
31. Roers, A., H. Hochkeppel, M. Horisberger, A. Hovanessian, and O. Haller. 1994. MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J. Infect. Dis. 169:807-813.
32. Roggendorf, M., and T. K. Tolle. 1995. The woodchuck: an animal model for human hepatitis B virus infection in man. Intervirology 38:100-112.
33. Ronni, T., K. Melen, A. Malygin, and I. Julkunen. 1993. Control of IFN-inducible MxA gene expression in human cells. J. Immunol. 150:1715-1726.
34. Salucci, V., M. Lu, L. Aurisiccbio, N. L. Monica, M. Roggendorf, and F. Palombo. 2002. Expression of a new woodchuck IFN-alpha gene by a helper-dependent adenoviral vector in woodchuck hepatitis virus-infected primary hepatocytes. J. Interferon Cytokine Res. 22:1027-1034.
35. Thimme, R., S. Wieland, C. Steiger, J. Ghrayeb, K. A. Reimann, R. H. Purcell, and F. V. Chisari. 2003. CD8+ T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 77:68-76.
36. Wong, D. K. H., A. M. Cheung, K. O'Rourke, C. D. Naylor, A. S. Detsky, and J. Heathcote. 1993. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive hepatitis B. A meta-analysis. Ann. Intern. Med. 119:312-323.
37. Yang, D., M. Lu, L. Hao, and M. Roggendorf. 2000. Molecular cloning and characterization of major histocompatibility complex calss1 cDNAs from woodchuck (Marmota monax). Tissue Antigens 55:548-557.
38. Zhou, T., J.-T. Guo, F. A. Nunes, K. L. Molnar-Kimber, J. M. Wilson, C. E. Aldrich, J. Saputelli, S. Litwin, L. D. Condreay, C. Seeger, and W. S. Mason. 2000. Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infection. J. Virol. 74:11754-11763.